Larson Financial Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.89M Sell
8,097
-843
-9% -$432K 0.12% 148
2025
Q4
$5.02M Sell
8,940
-232
-3% -$132K 0.17% 113
2025
Q3
$4.72M Sell
9,172
-1,690
-16% -$738K 0.16% 120
2025
Q2
$3.41M Buy
10,862
+811
+8% +$243K 0.14% 145
2025
Q1
$3.06M Buy
10,051
+542
+6% +$182K 0.15% 133
2024
Q4
$3.16M Buy
9,509
+788
+9% +$267K 0.16% 114
2024
Q3
$2.91M Buy
8,721
+244
+3% +$92.7K 0.17% 114
2024
Q2
$3.49M Buy
8,477
+172
+2% +$68.1K 0.24% 78
2024
Q1
$3.36M Buy
8,305
+106
+1% +$37.3K 0.26% 76
2023
Q4
$2.51M Sell
8,199
-70
-0.8% -$18.9K 0.22% 83
2023
Q3
$2M Buy
+8,269
New +$2.11M 0.2% 97
2019
Q1
Sell
-100
Closed -$5K 521
2018
Q4
$5K Buy
+100
New +$5.49K ﹤0.01% 275

Other funds holding MEDP

Larson Financial Group's MEDP Position: Q1 2026 in Review

Larson Financial Group reduced its Medpace (MEDP) stake by 9.4% in Q1 2026, selling an estimated $432K and leaving 8,097 shares worth $3.89M. The position accounts for 0.12% of the portfolio, ranked #148.

Larson Financial Group first reported a position in MEDP in Q4 2018 and has held it in 12 quarters since. The position peaked at $5.02M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Larson Financial Group held 8,097 shares of Medpace worth $3.89M as of Q1 2026.
  • Larson Financial Group sold 843 Medpace shares in Q1 2026, an estimated $432K.
  • Medpace made up 0.12% of Larson Financial Group's portfolio in Q1 2026, its #148 holding.
  • Larson Financial Group first reported a position in Medpace in Q4 2018 and has held it in 12 quarters since.
  • Larson Financial Group's Medpace position peaked at $5.02M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.